Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Reed

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Organic & Biomolecular Chemistry|August 31, 2007
Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activityToby Jackson, L W Lawrence Woo, Melanie N Trusselle, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 3, 2005
A letrozole-based dual aromatase-sulphatase inhibitor with in vivo activityPaul M Wood, L W Lawrence Woo, Anna Humphreys, et al.
Organic & Biomolecular Chemistry|November 2, 2007
Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activityToby Jackson, L W Lawrence Woo, Melanie N Trusselle, et al.
Annals of the New York Academy of Sciences|March 3, 2009
The development of steroid sulfatase inhibitors for hormone-dependent cancer therapyJoanna M Day, Atul Purohit, Helena J Tutill, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 25, 2003
The effects of 2-substituted oestrogen sulphamates on the growth of prostate and ovarian cancer cellsJoanna M Day, Simon P Newman, Alexander Comninos, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 25, 2003
Novel D-ring modified steroid derivatives as potent, non-estrogenic, steroid sulfatase inhibitors with in vivo activityDelphine S Fischer, Surinder K Chander, L W Lawrence Woo, et al.
International Journal of Cancer|March 3, 2004
Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamatesSimon P Newman, Mathew P Leese, Atul Purohit, et al.
Journal of Medicinal Chemistry|August 5, 2005
A-ring-substituted estrogen-3-O-sulfamates: potent multitargeted anticancer agentsMathew P Leese, Hatem A M Hejaz, Mary F Mahon, et al.
Anticancer Research|July 18, 2008
A comparison of two orally bioavailable anti-cancer agents, IRC-110160 and STX140Paul A Foster, C Stengel, Tauhid Ali, et al.
Molecular and Cellular Endocrinology|February 24, 2006
17Beta-hydroxysteroid dehydrogenase Type 1 and Type 2: association between mRNA expression and activity in cell linesJoanna M Day, Helena J Tutill, Simon P Newman, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Organic & Biomolecular Chemistry|August 31, 2007
Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activityToby Jackson, L W Lawrence Woo, Melanie N Trusselle, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 3, 2005
A letrozole-based dual aromatase-sulphatase inhibitor with in vivo activityPaul M Wood, L W Lawrence Woo, Anna Humphreys, et al.
Organic & Biomolecular Chemistry|November 2, 2007
Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activityToby Jackson, L W Lawrence Woo, Melanie N Trusselle, et al.
Annals of the New York Academy of Sciences|March 3, 2009
The development of steroid sulfatase inhibitors for hormone-dependent cancer therapyJoanna M Day, Atul Purohit, Helena J Tutill, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 25, 2003
The effects of 2-substituted oestrogen sulphamates on the growth of prostate and ovarian cancer cellsJoanna M Day, Simon P Newman, Alexander Comninos, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 25, 2003
Novel D-ring modified steroid derivatives as potent, non-estrogenic, steroid sulfatase inhibitors with in vivo activityDelphine S Fischer, Surinder K Chander, L W Lawrence Woo, et al.
International Journal of Cancer|March 3, 2004
Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamatesSimon P Newman, Mathew P Leese, Atul Purohit, et al.
Journal of Medicinal Chemistry|August 5, 2005
A-ring-substituted estrogen-3-O-sulfamates: potent multitargeted anticancer agentsMathew P Leese, Hatem A M Hejaz, Mary F Mahon, et al.
Anticancer Research|July 18, 2008
A comparison of two orally bioavailable anti-cancer agents, IRC-110160 and STX140Paul A Foster, C Stengel, Tauhid Ali, et al.
Molecular and Cellular Endocrinology|February 24, 2006
17Beta-hydroxysteroid dehydrogenase Type 1 and Type 2: association between mRNA expression and activity in cell linesJoanna M Day, Helena J Tutill, Simon P Newman, et al.
Pageof 8